In late March Battelle Labs in Columbus developed a technology to sterilize N95 masks for reuse, intending to provide 160,000 masks per day in Ohio and to send sterilizing machines to other areas of the US.[90] On March 29 the FDA approved the technology for limited use of up to 10,000 sterilizations per day.[90] DeWine issued a press release condemning this decision that afternoon.[90] Later on March 29, the FDA changed their position, and allowed full use of the technology.[91][92]